의약품용 젤라틴 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 유형별, 공급원별, 기능별, 최종사용자별, 지역별, 경쟁별(2020-2030년)
Pharmaceutical Gelatin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Source, By Function, By End User, By Region and Competition, 2020-2030F
상품코드:1714381
리서치사:TechSci Research
발행일:2025년 04월
페이지 정보:영문 181 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
의약품용 젤라틴 세계 시장은 2024년에 18억 9,000만 달러로 평가되며, 2030년에는 연평균 5.51%의 CAGR을 기록하며 26억 1,000만 달러에 달할 것으로 예상됩니다.
제약용 젤라틴은 생체적합성과 엄격한 안전 및 순도 기준을 충족하는 능력으로 인해 캡슐, 정제, 지혈제 등 의약품 제제에 널리 사용되는 중요한 부형제입니다. 동물성 콜라겐을 주원료로 하는 의약품용 젤라틴은 병원균, 알레르겐, 유해물질이 포함되지 않도록 멸균, 정제 등 엄격한 과정을 거쳐야 합니다. 약물의 안정성, 생체 이용률, 환자 순응도를 향상시키는 일관된 성능으로 다양한 치료 용도에 필수적인 역할을 하고 있습니다. 지역적 선호도 및 규제 지침에 따라 소, 돼지, 생선, 닭 등 동물성 젤라틴의 원료가 결정되는 경우가 많습니다. 경구용 제형에 대한 수요 증가와 의약품 제조 기술 발전으로 인해 세계 시장 확대가 지속되고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
18억 9,000만 달러
시장 규모 : 2030년
26억 1,000만 달러
CAGR : 2025-2030년
5.51%
급성장 부문
소프트 캡슐
최대 시장
북미
시장 촉진요인
제약 산업의 성장
주요 시장 과제
원자재 공급 및 가격 변동
주요 시장 동향
식물성 대체품으로의 전환
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 의약품용 젤라틴 시장 전망
시장 규모 및 예측
금액별
시장 점유율과 예측
유형별(A형, B형)
원료별(돼지, 우피, 우골, 생선, 가금류)
기능별(안정화, 증점, 겔화, 기타)
최종사용자별(하드 캡슐, 소프트 캡슐, 태블릿, 흡수성 지혈제, 기타)
기업별(2024년)
지역별
시장 맵
제6장 북미의 의약품용 젤라틴 시장 전망
시장 규모 및 예측
시장 점유율과 예측
북미 : 국가별 분석
미국
멕시코
캐나다
제7장 유럽의 의약품용 젤라틴 시장 전망
시장 규모 및 예측
시장 점유율과 예측
유럽 : 국가별 분석
프랑스
독일
영국
이탈리아
스페인
제8장 아시아태평양의 의약품용 젤라틴 시장 전망
시장 규모 및 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
중국
인도
한국
일본
호주
제9장 남미의 의약품용 젤라틴 시장 전망
시장 규모 및 예측
시장 점유율과 예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 의약품용 젤라틴 시장 전망
시장 규모 및 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
남아프리카공화국
사우디아라비아
아랍에미리트
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
인수합병
제품 출시
최근 동향
제13장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 능력
고객의 능력
대체품의 위협
제14장 경쟁 구도
Gelita AG
Trobas Pharmaceutical gelatine B.V
Rousselot SAS
Gelatines Weishardt SAS
Sterling Biotec Ltd.
Catalent, Inc
Nitta Pharmaceutical Gelatin India Limited
Aspire Pharmaceuticals
Gelco International
Lapi Gelatine S.p.a
제15장 전략적 제안
제16장 조사 회사 소개 및 면책사항
ksm
영문 목차
영문목차
The Global Pharmaceutical Gelatin Market was valued at USD 1.89 billion in 2024 and is projected to reach USD 2.61 billion by 2030, registering a CAGR of 5.51%. Pharmaceutical gelatin is a critical excipient widely used in drug formulations such as capsules, tablets, and hemostats due to its biocompatibility and ability to meet stringent safety and purity standards. Derived primarily from animal collagen, pharmaceutical gelatin undergoes rigorous processing, including sterilization and purification, to ensure it is free from pathogens, allergens, and harmful substances. Its consistent performance in enhancing drug stability, bioavailability, and patient compliance makes it indispensable across various therapeutic applications. Regional preferences and regulatory guidelines often dictate the source of gelatin-whether bovine, porcine, fish, or poultry. The growing demand for oral dosage forms, coupled with technological advances in pharmaceutical manufacturing, continues to propel market expansion globally.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 1.89 Billion
Market Size 2030
USD 2.61 Billion
CAGR 2025-2030
5.51%
Fastest Growing Segment
Soft Capsule
Largest Market
North America
Key Market Drivers
Growing Pharmaceutical Industry
The expanding pharmaceutical sector is a primary driver of the pharmaceutical gelatin market, with increasing demand for effective and patient-friendly dosage forms such as capsules. Gelatin plays a vital role in improving drug solubility, enabling controlled drug release, and enhancing the overall stability of active pharmaceutical ingredients (APIs). Regulatory bodies like the FDA and EMA recognize gelatin as a safe and effective excipient when manufactured under strict quality controls and Good Manufacturing Practices (GMP). This endorsement strengthens its widespread use in both conventional and advanced drug delivery systems. As pharmaceutical innovation continues to grow, particularly in personalized medicine and complex therapies, gelatin's functional versatility is expected to further solidify its market position.
Key Market Challenges
Raw Material Supply and Price Volatility
The pharmaceutical gelatin market faces notable challenges due to the reliance on animal-derived raw materials such as bovine and porcine collagen. Factors like disease outbreaks (e.g., African swine fever), climate events, and fluctuating livestock populations can disrupt supply chains and elevate production costs. Environmental concerns, ethical considerations, and rising interest in alternative materials also add complexity to sourcing decisions. Additionally, raw material costs are sensitive to variables such as feed prices, transportation, and currency fluctuations, leading to inconsistent pricing. Meeting stringent regulatory requirements for pharmaceutical-grade gelatin adds further layers of cost and operational effort. These dynamics collectively pose risks to production stability and profitability, particularly for manufacturers operating in price-sensitive markets.
Key Market Trends
Shift Towards Plant-Based Alternatives
The rising demand for sustainable, cruelty-free, and allergen-friendly products is driving interest in plant-based alternatives to animal-derived pharmaceutical gelatin. These alternatives cater to growing vegan and vegetarian populations and meet religious or cultural dietary restrictions. They also present a more environmentally sustainable option, often requiring fewer natural resources and generating lower greenhouse gas emissions. Recent advancements in food and material science have enabled the development of plant-based gelling agents that mimic the functional properties of traditional gelatin. As pharmaceutical companies seek to diversify their excipient sources, plant-based gelatin substitutes are gaining attention for their potential to meet both functional and ethical criteria. However, achieving comparable performance and regulatory approval remains a focus of ongoing innovation.
Key Market Players
Gelita AG
Trobas Pharmaceutical gelatine B.V
Rousselot SAS
Gelatines Weishardt SAS
Sterling Biotec Ltd.
Catalent, Inc
Nitta Pharmaceutical Gelatin India Limited
Aspire Pharmaceuticals
Gelco International
Lapi Gelatine S.p.a
Report Scope:
In this report, the Global Pharmaceutical Gelatin Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Pharmaceutical Gelatin Market, By Type:
Type A
Type B
Pharmaceutical Gelatin Market, By Source:
Porcine
Bovine Skin
Bovine Bone
Fish
Poultry
Pharmaceutical Gelatin Market, By Function:
Stabilizing
Thickening
Gelling
Others
Pharmaceutical Gelatin Market, By End User:
Hard Capsule
Soft Capsule
Tablet
Absorbable Hemostat
Others
Pharmaceutical Gelatin Market, By Region:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
South Korea
Australia
Japan
Europe
Germany
France
United Kingdom
Spain
Italy
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Pharmaceutical Gelatin Market.
Available Customizations:
Global Pharmaceutical Gelatin Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. Voice of Customer
5. Global Pharmaceutical Gelatin Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Type A, Type B)
5.2.2. By Source (Porcine, Bovine Skin, Bovine Bone, Fish, Poultry)
5.2.3. By Function (Stabilizing, Thickening, Gelling, Others)
5.2.4. By End User (Hard Capsule, Soft Capsule, Tablet, Absorbable Hemostat, Others)
5.2.5. By Company (2024)
5.2.6. By Region
5.3. Market Map
6. North America Pharmaceutical Gelatin Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Source
6.2.3. By Function
6.2.4. By End User
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Pharmaceutical Gelatin Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Source
6.3.1.2.3. By Function
6.3.1.2.4. By End User
6.3.2. Mexico Pharmaceutical Gelatin Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Source
6.3.2.2.3. By Function
6.3.2.2.4. By End User
6.3.3. Canada Pharmaceutical Gelatin Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Source
6.3.3.2.3. By Function
6.3.3.2.4. By End User
7. Europe Pharmaceutical Gelatin Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Source
7.2.3. By Function
7.2.4. By End User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. France Pharmaceutical Gelatin Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Source
7.3.1.2.3. By Function
7.3.1.2.4. By End User
7.3.2. Germany Pharmaceutical Gelatin Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Source
7.3.2.2.3. By Function
7.3.2.2.4. By End User
7.3.3. United Kingdom Pharmaceutical Gelatin Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Source
7.3.3.2.3. By Function
7.3.3.2.4. By End User
7.3.4. Italy Pharmaceutical Gelatin Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Source
7.3.4.2.3. By Function
7.3.4.2.4. By End User
7.3.5. Spain Pharmaceutical Gelatin Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Source
7.3.5.2.3. By Function
7.3.5.2.4. By End User
8. Asia-Pacific Pharmaceutical Gelatin Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Source
8.2.3. By Function
8.2.4. By End User
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Pharmaceutical Gelatin Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Source
8.3.1.2.3. By Function
8.3.1.2.4. By End User
8.3.2. India Pharmaceutical Gelatin Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Source
8.3.2.2.3. By Function
8.3.2.2.4. By End User
8.3.3. South Korea Pharmaceutical Gelatin Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Source
8.3.3.2.3. By Function
8.3.3.2.4. By End User
8.3.4. Japan Pharmaceutical Gelatin Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Source
8.3.4.2.3. By Function
8.3.4.2.4. By End User
8.3.5. Australia Pharmaceutical Gelatin Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Source
8.3.5.2.3. By Function
8.3.5.2.4. By End User
9. South America Pharmaceutical Gelatin Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Source
9.2.3. By Function
9.2.4. By End User
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Pharmaceutical Gelatin Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Source
9.3.1.2.3. By Function
9.3.1.2.4. By End User
9.3.2. Argentina Pharmaceutical Gelatin Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Source
9.3.2.2.3. By Function
9.3.2.2.4. By End User
9.3.3. Colombia Pharmaceutical Gelatin Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Source
9.3.3.2.3. By Function
9.3.3.2.4. By End User
10. Middle East and Africa Pharmaceutical Gelatin Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Source
10.2.3. By Function
10.2.4. By End User
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Pharmaceutical Gelatin Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Source
10.3.1.2.3. By Function
10.3.1.2.4. By End User
10.3.2. Saudi Arabia Pharmaceutical Gelatin Market Outlook
